Menu

Ayala Pharmaceuticals, Inc. ADXS

Full chart Compare
Set alert

Price alert · ADXS

All alert types
0.60 USD 0.00 (+0.00%)

At closeFeb 4, 2026, 4:00 PM EST

0.0846 Day range 0.60355
0.121 52-week range 1.57
YTD
+1,405.11%
1 year
+2,014.01%

Revenue & Expenses

Other Income → Expenses: $28.00KExpenses → Selling, General & Admin: $12.19MExpenses → Research & Development: $24.08MExpenses → Interest Expense: $15.75MIncome Tax Benefit → Expenses: $3.91MNet Loss → Expenses: $48.07MRevenue → Cost of Revenue: $13.00KOther Income$28.00KIncome Tax Benefit$3.91MNet Loss$48.07MCost of Revenue$13.00KExpenses$52.01MSelling, General & Admin$12.19MResearch & Development$24.08MInterest Expense$15.75MRevenue$13.00K

Latest period ending Oct 31, 2022 · select a line to chart its full history

ADXS annual income statement
Fiscal yearFY 2022 Oct 31, 2022FY 2021 Oct 31, 2021FY 2020 Oct 31, 2020FY 2019 Oct 31, 2019FY 2018 Oct 31, 2018
250.00K3.24M253.00K20.88M6.06M
250.00K3.24M253.00K20.88M6.06M
-19.31M-18.79M-26.45M-17.97M-70.38M
-14.36M-17.86M-26.47M-16.61M-66.52M
-8.46-11.20-34.40-87.20-1,548.80
ADXS annual balance sheet
Fiscal yearFY 2022 Oct 31, 2022FY 2021 Oct 31, 2021FY 2020 Oct 31, 2020FY 2019 Oct 31, 2019FY 2018 Oct 31, 2018
25.21M41.61M25.18M32.36M45.12M
25.93M46.78M38.53M45.26M62.27M
2.30M7.89M8.35M5.73M38.22M
12.00K40.00K6.02M00
23.63M38.89M30.18M39.53M24.05M
ADXS annual cash flow
Fiscal yearFY 2022 Oct 31, 2022FY 2021 Oct 31, 2021FY 2020 Oct 31, 2020FY 2019 Oct 31, 2019FY 2018 Oct 31, 2018
-15.28M-15.44M-21.94M-36.13M-62.13M
-166.00K-11.00K-748.00K-1.20M43.56M
-956.00K31.89M15.50M24.57M39.20M
35.00K449.00K029.00K-1.43M
-16.41M16.44M-7.18M-12.76M20.63M